Dolat Capital is bullish on Biocon and has recommended accumulate rating on the stock with a target of Rs 536 in its October 27, 2014 research report.
Dolat Capital has come out with its report on preferred buy list. The research firm has recommended to buy 13 stocks in its research report dated August 25, 2014.
Systematix Shares has recommended traders to buy Biocon, Andhra Bank for the target price of Rs 467 and Rs 58 respectively in its research report dated March 03, 2014.
IIFL is bullish on Biocon and has recommended to buy the stock above Rs 272 with a stop loss of Rs 264 for the target price of Rs 288, in its March 06, 2013 research report.
Sushil Finance has recommended hold rating on Biocon with a target of Rs 312, in its January 29, 2013 research report.
Motilal Oswal has maintained neutral rating on Biocon with a target of Rs 315 in its January 28, 2013 research report.
Dolat Capital is bullish on Biocon and has recommended accumulate rating on the stock with a target of Rs 312 in its January 28, 2013 research report.
IFCI Financial has come out with its report on Diwali picks.
Dolat Capital is bullish on Biocon and has recommended accumulate rating on the stock with a target price of Rs 287 in its November 1, 2012 research report.
SKP Securities is bullish on Biocon and has recommended buy rating on the stock with a target price of Rs 338 in its October 08, 2012 research report.
Dolat Capital is bullish on Biocon and has recommended accumulate rating on the stock with a target price of Rs 260 in its July 27, 2012 research report.
ICICIdirect.com is bullish on Biocon and has recommended buy rating on the stock with a target price of Rs 313, in its April 30, 2012 research report.
A C Choksi is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 269 in its April 9, 2012 research report.
GEPL Capital has come out with its report on to trading picks. The research firm maintains buy rating on Ashok Leyland and sell rating on Biocon.
Sushil Finance is bullish on Biocon and has recommended buy rating on the stock with a target price of Rs 325 in its January 30, 2012 research report.
Unicon Investment is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 320 in its January 30, 2012 research report.
Dolat Capital is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 373 in its January 25, 2012 research report.
IIFL is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 276 in its January 18, 2012 research report.
ICICIdirect.com has come out with its report on Nifty Future, Bank of India (BOI), Polaris Software, Biocon and IDFC
GEPL Capital has come out with its report on top trading picks. The research firm recommends buying Ashok Leyland, Jubilant Food and selling Biocon.
Dolat Capital is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 421 in its December 1, 2011 research report.
According to IIFL, traders can sell Biocon November future below Rs 325 with stop loss of Rs 331 for target of Rs 313, in its November 16, 2011 research report.
Motilal Oswal has maintained neutral rating on Biocon with a target of Rs 364, in its October 21, 2011 research report.
Unicon Investment has come out with its report on various stocks.
Unicon Investment is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 480 in its July 23, 2011 research report.